Market Scope
The global obesity management market size is poised to inflate to a valuation of USD 9.34 billion by 2025. It can exhibit a CAGR of 8.4% over the forecast period.
The lifestyle of convenience, consumption of snacks, large number of obese individuals, and availability of obesity treatment methods are major drivers of the market. According to a study in 2016, out of 2 billion overweight individuals, close to 650 million were found to be obese. The risk of being diagnosed with cardiovascular disease and diabetes due to obesity can provide plenty of growth opportunities to the global obesity management market.
The global obesity management market report compiled by Market Research Future (MRFR) contains insights, hurdles, measures, and other dynamic factors for the period of 2019 to 2025 (forecast period). The COVID-19 pandemic and its effect on the market has been noted.
Awareness of obesity management, presence of various healthy diets, option of bariatric surgery, and prevalence of lifestyle diseases can drive the market growth over the forecast period. Public health intervention campaigns endorsed by governments are likely to facilitate in market growth. Furthermore, the presence of nutrition experts and establishment of fitness centers can boost the global obesity management market.
Segmentation
The global market for obesity management, by type, is divided into medication and surgery. Moreover, the medication segment is further classified into liraglutide, orlistat, lorcaserin, bupropion and naltrexone, and phentermine and topiramate. Furthermore, the surgery is sub-segmented into laparoscopic adjustable gastric band, gastric sleeve, and gastric bypass.
Global Weight Loss and Obesity Management Market by Type [Medication (Orlistat, Lorcaserin, Phentermine and Topiramate, Bupropion and Naltrexone and Liraglutide) and Surgery (Laparoscopic Adjustable Gastric Band, Gastric Sleeve and Gastric Bypass)] and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2025Global Weight Loss and Obesity Management Market In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenueMajor Key PlayersThe key strategies followed by the players operating in the global Weight Loss and Obesity Management Market were innovation, product development, acquisition, and expansion.Pfizer Inc. (US), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc.
(UK), AstraZeneca (UK), Herbalife Ltd. (US), Apollo Endosurgery (US), and Ethicon, Inc. (US).Market Segment AnalysisGlobal Weight Loss and Obesity Management Market, by TypeMedicationOrlistatLorcaserinPhentermine and TopiramateBupropion and NaltrexoneLiraglutideSurgeryLaparoscopic Adjustable Gastric BandGastric SleeveGastric BypassOthersKey Study Highlights:This report for Weight Loss and Obesity Management Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.
The report also gives a broad study of the different market segments and regions.Regional AnalysisGeographically, the global Weight Loss and Obesity Management Market has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.Browse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/obesity-management-market-2690 About Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
The global obesity management market is expected to increase at a y-o-y growth rate of over 4.9% and reach US$ 1,078.9 Mn in revenues in 2027. North America and APEJ has collectively accounted for nearly 47.1% revenue share of the obesity management market in 2016. The increasing population of diabetes people worldwide and increasing prevalence of lifestyle diseases are some of the major factors favouring the growth of the global obesity management market. Increasing awareness about the health concerns due to obesity and overweight resulting in the increasing demand for the anti-obesity drugs and bariatric procedures which fuel the growth of the global obesity management market. Asia Pacific and MEA regions are the highest population regions. The increase in health care infrastructure and increasing medical tourism in these regions is expected to play an important role in driving growth of global obesity management market.
Report For Sample with Table of Contents@ https://www.researchreportinsights.com/report/sample/110114820/Obesity-Management-Market
The rise in investments to develop novel anti-obesity drugs and the strategic collaborations among companies, research institutes and universities for novel drug development and patent transfer are also anticipated to fuel the growth of this market over the forecast period. The increasing focus on body toning and grooming therapy as greater emphasis on the aesthetic appearance is also one of the important factor fuelling the revenue growth of the global obesity management market.
Global Obesity Management Market Revenues to Grow by Over 4.9% in 2017 to Reach US$ 1,078.9 Mn in Revenues in 2027: RRI Report
On the basis of drugs type, the obesity management market is segmented into bupropion and naltrexone, orlistat, lorcaserin, phentermine and topiramate, and Liraglutide. The liraglutide drug is expected to contribute the highest market share of 34.7% in 2027 and expected to register a significant CAGR of 6.2% during the forecast period 2027. Orlistat drug will have the major market share, followed by liraglutide. The availability of orlistat throughout the world is expected to boost the market over the forecast period. Gastric sleeve surgery will remain the largest segment by the surgery, accounted for over 39.6% revenue share of the market in 2016. The Increasing preference to the gastric sleeve surgery due to shorter hospital stays, faster recovery with the smaller scars and less pain as compared to other surgical procedures.
Request For Report Discount@ https://www.researchreportinsights.com/report/discount/110114820/Obesity-Management-Market
The developing medical industry in respect to advanced infrastructure and increasing medical tourism in the developing countries from the APEJ such as China, India will continue to have a positive impact on obesity management market in APEJ. The emergence of targeted and combination treatment in the North America and Western Europe such as a combination of drugs along with the bariatric treatment and physical exercise is anticipated to boost the growth of the obesity management market over a forecast period. The rise in discretionary funding for the research and development activities for the novel anti-obesity drugs will also drive the market in the North America and Western Europe. The MEA is at a nascent stage to the global obesity management market and expected to show a moderate growth over a forecast period.
F Hoffmann La Roche Ltd, GlaxoSmithKline plc., Orexigen Therapeutics, Inc., Arena Pharmaceuticals, Inc., VIVUS, Inc. and Novo Nordisk A/S. are leading players in the global obesity management market. Companies in the global obesity management market are focusing on strategic alliances such as strategic agreements, collaborations, rising research and development activities, new product launches, joint ventures, partnerships, and mergers & acquisitions to sustain in the overall competition in the obesity management market.
Research Report Insights (RRI) is a leading market intelligence and consulting firm. We deliver a host of services including custom research reports, syndicated research reports, and consulting services which are personalised in nature. RRI delivers a complete packaged solution to clients; this combines current market intelligence, technology inputs, statistical anecdotes, valuable growth insights, 360-degree view of the competitive framework, and anticipated market trends.
Our research services cover global as well as regional emerging markets such as BRICS, GCC, and ASEAN. Our offerings cover a broad spectrum of verticals which include Oil and Gas, Chemicals, Materials, Energy, Technology, Automotive, and Retail. The operating model of RRI blends cross-disciplinary research experience to deploy insightful, in-depth, and actionable research.
Contact Us:
Research Report Insights
42 joseph street,
Portcarling P0B 1J0,
Muskoka, Ontario, Canada
T: +1-631-721-4201
Email: [email protected]
Web Site: http://www.researchreportinsights.com
Phone - (+91) 7875758555
Report Analysis@ https://www.researchreportinsights.com/report/rd/110114820/Obesity-Management-Market
Weight Loss and Obesity Management market research report displays key data and information about several factors which helps achieve success in the competitive marketplace.
Summary of the market is analysed with respect to market players who are mainly customers, businesses or clients.
SWOT analysis is the standard, prominent and full-proof method to perform the market research study which is used to formulate this particular Weight Loss and Obesity Management market report.
To be ahead of the competition, a systematic idea about the competitive landscape, their product range, their strategies, and future prospects are very important.
This market document also comprises of key performers, vendors, and suppliers.The weight loss and obesity management market is expected to witness market growth at a rate of 6.74% in the forecast period of 2021 to 2028 and is expected to reach USD 360.55 million by 2028.A thorough market study and investigation of trends in consumer and supply chain dynamics covered in this report helps businesses draw the strategies about sales, marketing, and promotion.
Besides, market research performed in this Weight Loss and Obesity Management report puts a light on the challenges, market structures, opportunities, driving forces, and competitive landscape for the business.
With the slowdown in world economic growth, the Weight Loss/Obesity Management industryhas also suffered a certain impact, but still maintained a relatively optimistic growth, the pastfour years, Weight Loss/Obesity Management market size to maintain the average annualgrowth rate of 4.90% from 114660 million $ in 2014 to 132340 million $ in 2017, BisReportanalysts believe that in the next few years, Weight Loss/Obesity Management market size will befurther expanded, we expect that by 2022, The market size of the Weight Loss/ObesityManagement will reach 165490 million $.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/2224610 This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit,interview record, business distribution etc., these data help the consumer know about thecompetitors better.
This report also covers all the regions and countries of the world, whichshows a regional development status, including market size, volume and value, as well as pricedata.
Besides, the report also covers segment data, including: type segment, industry segment,channel segment etc.
Also coverdifferent industries clients information, which is very important for the manufacturers.
Section 1: Free——DefinitionSection (2 3): 1200 USD——Manufacturer DetailAjinomoto Co., Inc.Allergan, Inc.Amer Sports CorporationAtkins Nutritionals, Inc.Brunswick CorporationCynosure, Inc.ComEquinoxFitness First Group, Ltd.Gold’S Gym International, Inc.Herbalife, Ltd.Icon Health & Fitness, Inc.Johnson Health Tech.